Mainz Biomed N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
0.6917
-0.0457 (-6.20%)
At close: Mar 16, 2026, 4:00 PM EDT
0.7001
+0.0084 (1.21%)
After-hours: Mar 16, 2026, 6:00 PM EDT
Mainz Biomed Employees
As of December 31, 2024, Mainz Biomed had 26 total employees, including 19 full-time and 7 part-time employees. The number of employees decreased by 45 or -63.38% compared to the previous year.
Employees
26
Change (1Y)
-45
Growth (1Y)
-63.38%
Revenue / Employee
$25,382
Profits / Employee
-$729,658
Market Cap
8.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 26 | -45 | -63.38% | 19 | 7 |
| Dec 31, 2023 | 71 | 7 | 10.94% | 65 | 6 |
| Dec 31, 2022 | 64 | - | - | 58 | 6 |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| XWELL | 312 |
| bioAffinity Technologies | 57 |
| Imunon | 25 |
| SeaStar Medical Holding | 19 |
QUCY News
- 3 days ago - Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY - GlobeNewsWire
- 5 days ago - Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors - GlobeNewsWire
- 2 months ago - Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting - GlobeNewsWire
- 4 months ago - Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America - GlobeNewsWire
- 4 months ago - Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025 - GlobeNewsWire
- 4 months ago - Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS) - GlobeNewsWire
- 5 months ago - Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project - GlobeNewsWire
- 6 months ago - Mainz Biomed Announces Registration of ColoAlert in the United Kingdom - GlobeNewsWire